NCT00115141View on ClinicalTrials.gov

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

April 30, 2004

Conditions
Warts
Interventions
DRUG

Resiquimod

Sponsors
All Listed Sponsors
lead

Graceway Pharmaceuticals, LLC

INDUSTRY